- Conditions
- Vocal Cord Paralysis
- Interventions
- Voice Rest, No Voice Rest
- Behavioral
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 601–624
of 13,921
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Acute Ischemic Stroke
- Interventions
- TAK-755, Placebo
- Biological · Other
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 222 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 9
- States / cities
- Scottsdale, Arizona • Tucson, Arizona • San Francisco, California + 6 more
- Conditions
- Venous Vascular Closure
- Interventions
- MYNX CONTROL™ Venous Vascular Closure Device 6F-12F
- Device
- Lead sponsor
- Cordis US Corp.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 352 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 14
- States / cities
- Phoenix, Arizona • Lakewood, Colorado • Miami, Florida + 10 more
- Conditions
- Patient Discharge, Urinary Complication
- Interventions
- Backfill
- Procedure
- Lead sponsor
- University of Tennessee
- Other
- Eligibility
- 18 Years to 80 Years · Female only
- Enrollment
- 112 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Acute Respiratory Distress Syndrome, Influenza, H1N1 Influenza
- Interventions
- Rosuvastatin (crestor), Placebo
- Drug
- Lead sponsor
- Gordon Bernard
- Other
- Eligibility
- 13 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 21
- States / cities
- Little Rock, Alaska • Phoenix, Arizona • Stanford, California + 17 more
- Conditions
- Tenodesis, Tenotomy
- Interventions
- Biceps Tenodesis, Self-locking "T" Tenotomy
- Procedure
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Malocclusion, Angle Class II
- Interventions
- Aligners, Clear braces
- Other
- Lead sponsor
- Texas A&M University
- Other
- Eligibility
- 17 Years and older
- Enrollment
- 78 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2019
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Coronary Artery Disease, Atrial Fibrillation
- Interventions
- Liposomal bupivacaine, Placebo
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Control Group, Mexico-based NSS FOPL, Brazil-based NSS FOPL
- Interventions
- Experimental : Mexico-based NSS FOPL, Experimental : Brazil-based NSS FOPL
- Other
- Lead sponsor
- George Washington University
- Other
- Eligibility
- 20 Years and older
- Enrollment
- 1,068 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Metastatic Pancreatic Cancer
- Interventions
- MRTX849
- Drug
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Type 2 Diabetes
- Interventions
- dapagliflozin, placebo, metformin
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 389 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 111
- States / cities
- Bayou La Batre, Alabama • Birmingham, Alabama • Huntsville, Alabama + 107 more
- Conditions
- Infectious Diarrhea
- Interventions
- Biofire Film Array Gastrointestinal Panel
- Diagnostic Test
- Lead sponsor
- Andrew Meltzer
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 74 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Heart Failure
- Interventions
- IASD System II implant, intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)
- Device · Other
- Lead sponsor
- Corvia Medical
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 608 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2026
- U.S. locations
- 44
- States / cities
- Phoenix, Arizona • Tucson, Arizona • La Jolla, California + 36 more
- Conditions
- Chronic Sinusitis, Nasal Polyps
- Interventions
- Biologic Agents
- Biological
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 504 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 5
- States / cities
- Phoenix, Arizona • Gainesville, Florida • Portland, Oregon + 2 more
- Conditions
- Coronary Artery Disease, Angina Pectoris, Unstable Angina, Acute Coronary Syndrome
- Interventions
- Coronary Computed Tomography Angiography, Stress Nuclear Myocardial Perfusion Imaging
- Procedure
- Lead sponsor
- Montefiore Medical Center
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2013
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Hypertension, Prehypertension
- Interventions
- Intervention
- Behavioral
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 271 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- NON-ALCOHOLIC STEATOHEPATITIS
- Interventions
- DA-1241, Sitagliptin, DA-1241 Placebo, Sitagliptin Placebo
- Drug
- Lead sponsor
- NeuroBo Pharmaceuticals Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 18
- States / cities
- Coronado, California • Montclair, California • Panorama City, California + 12 more
- Conditions
- Coronary Artery Disease
- Interventions
- Percutaneous Mechanical Circulatory Support
- Device
- Lead sponsor
- Kardion Inc
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 310 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 18
- States / cities
- Chandler, Arizona • Scottsdale, Arizona • Little Rock, Arkansas + 15 more
- Conditions
- Hypersensitivity, Food Allergy, Hypersensitivity, Food, Peanut Hypersensitivity, Peanut Allergy
- Interventions
- Omalizumab, Dupilumab, Placebo for Dupilumab, Placebo for Omalizumab
- Drug · Other
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 4 Years to 55 Years
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 3
- States / cities
- Los Angeles, California • Palo Alto, California • San Diego, California
- Conditions
- Hepatitis C
- Interventions
- Simplified HCV care within a mobile medical unit
- Other
- Lead sponsor
- Family Health Centers of San Diego
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Lymphoma, Non-Hodgkin
- Interventions
- Granulocyte colony-stimulating factor plus plerixafor, Granulocyte colony-stimulating factor plus placebo
- Drug
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Eligibility
- 18 Years to 78 Years
- Enrollment
- 298 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 31
- States / cities
- Phoenix, Arizona • Duarte, California • Denver, Colorado + 23 more
- Conditions
- Alzheimer Disease, Mild Cognitive Impairment
- Interventions
- Pramlintide challenge test
- Drug
- Lead sponsor
- Boston University
- Other
- Eligibility
- 60 Years to 90 Years
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 3
- States / cities
- Indianapolis, Indiana • Boston, Massachusetts • Jamaica Plain, Massachusetts
- Conditions
- Wounds and Injuries
- Interventions
- V.A.C.Ulta with Prontosan instillation, V.A.C.Ulta without instillation
- Device
- Lead sponsor
- KCI USA, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 181 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 7
- States / cities
- Washington D.C., District of Columbia • Miami, Florida • Chicago, Illinois + 4 more
- Conditions
- Chronic Disease of Cardiovascular System, Multiple Chronic Conditions, Chronic Disease
- Interventions
- MOCHA
- Behavioral
- Lead sponsor
- University of Massachusetts, Amherst
- Other
- Eligibility
- 35 Years to 70 Years · Male only
- Enrollment
- 261 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2021
- U.S. locations
- 2
- States / cities
- Amherst, Massachusetts • Springfield, Massachusetts